Which drug is best for a patient with type 2 diabetes and heart failure?

被引：1
|
作者：
Clawson, Rebecca [1 ]
Weidman-Evans, Emily [1 ]
Fort, Ashley [1 ]
机构：
[1] LSUHSC Sch Allied Hlth Shreveport, Shreveport, LA USA
来源：
JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS | 2021年 / 34卷 / 07期
关键词：
diabetes; heart failure; SGLT-2; inhibitors; HFrEF; thiazolidinediones; metformin; CARDIOVASCULAR OUTCOMES; METFORMIN; MELLITUS; MORTALITY; DISEASE;
D O I：
10.1097/01.JAA.0000743004.83284.cc
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Heart failure is twice as common in men with type 2 diabetes than those without it and is almost five times greater in women with diabetes. Ideally, effective treatment for one condition also will help with the other; certainly, clinicians should not prescribe a medication that will potentially worsen one of the conditions, if avoiding it is at all possible. This article reviews the effects of diabetes medications on heart failure outcomes.
引用
收藏
页码：49 / 52
页数：4
相关论文
共 50 条
  • [21] Glucose-lowering drugs and heart failure: implications of recent cardiovascular outcome trials in type 2 diabetes
    Cattadori, Gaia
    Pantanetti, Paola
    Ambrosio, Giuseppe
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2019, 157
  • [22] Aiming for the Best Control of Glycemia in Patients With Heart Failure and Type 2 Diabetes The "Sweet Spot"
    Weinrauch, Larry A.
    Lewis, Eldrin F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (05) : 429 - 431
  • [23] Heart Failure Considerations of Antihyperglycemic Medications for Type 2 Diabetes
    Standl, Eberhard
    Schnell, Oliver
    McGuire, Darren K.
    CIRCULATION RESEARCH, 2016, 118 (11) : 1830 - 1843
  • [24] Heart failure risk and major cardiovascular events in diabetes: an overview of within-group differences in non-insulin antidiabetic treatment
    Terlizzese, Paola
    Losurdo, Fabrizio
    Iacoviello, Massimo
    Aspromonte, Nadia
    HEART FAILURE REVIEWS, 2018, 23 (03) : 469 - 479
  • [25] Contemporary choice of glucose lowering agents in heart failure patients with type 2 diabetes
    Katsiki, Niki
    Kazakos, Kyriakos
    Triposkiadis, Filippos
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (17) : 1957 - 1974
  • [26] Diabetes and Heart Failure A Marriage of Inconvenience
    Mehta, Adi
    Bhattacharya, Sanjeeb
    Estep, Jerry
    Faiman, Charles
    CLINICS IN GERIATRIC MEDICINE, 2020, 36 (03) : 447 - +
  • [27] Comparing the risks of hospitalized heart failure associated with glinide, sulfonylurea, and acarbose use in type 2 diabetes: A nationwide study
    Lee, Yen-Chieh
    Chang, Chia-Hsuin
    Dong, Yaa-Hui
    Lin, Jou-Wei
    Wu, Li-Chiu
    Hwang, Jing-Shiang
    Chuang, Lee-Ming
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2017, 228 : 1007 - 1014
  • [28] Treatment of patients with heart failure and type 2 diabetes: a review of the literature
    Fabbri, Elisa
    Nizzoli, Maurizio
    ITALIAN JOURNAL OF MEDICINE, 2019, 13 (04) : 205 - 224
  • [29] Clinical and echocardiographic characteristics in patients with heart failure and type 2 diabetes
    Jordhani, Mikel
    Seiti, Joana
    Barrios, Vivencio
    FUTURE CARDIOLOGY, 2022, 18 (07) : 569 - 576
  • [30] Predictors of heart failure development in type 2 diabetes: a practical approach
    Verma, Subodh
    Sharma, Abhinav
    Kanumilli, Naresh
    Butler, Javed
    CURRENT OPINION IN CARDIOLOGY, 2019, 34 (05) : 578 - 583
12345